Skip to content
Screener

SANUWAVE Health, Inc. SNWV Q4 2025 Annual earnings

Reported March 26, 2026 · Before market open

Revenue$13.4MBeat by $144.0K
EPS$0.03Miss by $0.14
Revenue estimate$13.3M
EPS estimate$0.17

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$13.8M
EPS estimate$0.01

Financials

Q4 2025

Income statement

See full
Revenue$13.4M+29.7%
Gross profit$10.0M+24.4%
Operating income$2.0M-0.4%
Net income$7.8M+159%
EPS (diluted)$0.20+118%

Balance sheet

See full
Cash & equivalents$12.0M+16.8%
Total debt$16.7M+4,444%
Total equity$1.6M+110%
Total assets$37.3M+24.0%

Cash flow

See full
Operating cash flow$3.3M+348%
CapEx$96.0K-59.3%
Free cash flow$3.2M+538%

Valuation & ratios

Profitability

See full
Gross margin77.1%+1.9pp
Operating margin11.2%-0.6pp
Net margin27%+15.1pp
FCF margin4.4%—

Returns & leverage

See full
Debt / equity10.3×—
Current ratio1.4×+1.0×

Segments

By segment

See full
Reportable Segment$13.1M+26.8%

By product

See full
System revenue$6.8M+73.5%

FAQ

When did SANUWAVE Health, Inc. report Q4 2025 earnings?
SANUWAVE Health, Inc. (SNWV) reported Q4 2025 earnings on March 26, 2026 before market open.
What were SANUWAVE Health, Inc.'s Q4 2025 revenue and EPS?
SANUWAVE Health, Inc. reported revenue of $13.4M and eps of $0.03 for Q4 2025.
Did SANUWAVE Health, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $13.3M by $144.0K. EPS missed the consensus estimate of $0.17 by $0.14.
How did SANUWAVE Health, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 29.7% from $10.3M a year earlier.
Where can I find SANUWAVE Health, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-021464) and the 10-K periodic report (0001628280-26-021443) directly on SEC EDGAR. The filing index links above go to sec.gov.